Directori de persones
Nuria Eritja Sanchez

Nuria Eritja Sanchez

Grau: Doctor/a

973 70 29 37
neritja(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-1347-2015

Grups

Publicacions

  • Cuevas, D; Valls, J; Gatius, S; Roman-Canal, B; Estaran, E; Dorca, E; Santacana, M; Vaquero, M; Eritja, N; Velasco, A; Matias-Guiu, X

    Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    VIRCHOWS ARCHIV 474 585-598. .

    [doi:10.1007/s00428-018-02516-2]

  • Felip, I; Moiola, CP; Megino-Luque, C; Lopez-Gil, C; Cabrera, S; Sole-Sanchez, S; Muñoz-Guardiola P; Megias-Roda, E; Perez-Montoyo, H; Alfon, J; Yeste-Velasco, M; Santacana, M; Dolcet, X; Reques, A; Oaknin, A; Rodriguez-Freixinos, V; Lizcano, JM; Domènech C; Gil-Moreno, A; Matias-Guiu, X; Colas, E; Eritja, N

    Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

    GYNECOLOGIC ONCOLOGY 153 425-435. .

    [doi:10.1016/j.ygyno.2019.03.002]

  • Dosil, MA; Navaridas, R; Mirantes, C; Tarragona, J; Eritja, N; Felip, I; Urdanibia, I; Megino, C; Domingo, M; Santacana, M; Gatius, S; Piñol C; Barcelo, C; Maiques, O; Macia, A; Velasco, A; Vaquero, M; Matias-Guiu, X; Dolcet, X

    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    JOURNAL OF PATHOLOGY 247 72-85. .

    [doi:10.1002/path.5168]

  • Perez-Montoyo, H; Yeste-Velasco, M; Sole-Sanchez, S; Bragado, P; Colas-Ortega, E; Eritja, N

    Development of TRIB3 as a novel preclinical and clinical pharmacodynamic biomarker for ABTL0812.

    Journal of Clinical Oncology 36 -. .

    [doi:10.1200/JCO.2018.36.15_suppl.e14556]

  • Zhu, C; Farre, G; Zanga, D; Lloveras, J; Michelena, A; Ferrio, JP; Voltas, J; Slafer, G; Savin, R; Albajes, R; Eizaguirre, M; Lopez, C; Cantero-Martinez, C; Diaz-Gomez, J; Nogareda, C; Moreno, JA; Angulo, E; Estany, J; Pena, RN; Tor, M; Portero-Otin, M; Eritja, N; Arjo, G; Serrano, JCE; Matias-Guiu, X; Twyman, RM; Sandmann, G; Capell, T; Christou, P

    High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition

    PHYTOCHEMISTRY REVIEWS 17 195-209. .

    [doi:10.1007/s11101-017-9506-4]

  • Gatius, S; Cuevas, D; Fernandez, C; Roman-Canal, B; Adamoli, V; Piulats, JM; Eritja, N; Martin-Satue, M; Moreno-Bueno, G; Matias-Guiu, X

    Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology 85 35-40. .

    [doi:10.1159/000475529]

  • Eritja, N; Jove, M; Fasmer, KE; Gatius, S; Portero-Otin, M; Trovik, J; Krakstad, C; Sol, J; Pamplona, R; Haldorsen, IS; Matias-Guiu, X

    Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget 8 109018-109026. .

    [doi:10.18632/oncotarget.22558]

  • Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

    A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

    CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

    [doi:10.1038/cdd.2017.73]

  • Dosil, MA; Mirantes, C; Eritja, N; Felip, I; Navaridas, R; Gatius, S; Santacana, M; Colàs E; Moiola, C; Schoenenberger, JA; Encinas, M; Gari, E; Matias-Guiu, X; Dolcet, X

    Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    JOURNAL OF PATHOLOGY 242 152-164. .

    [doi:10.1002/path.4896]

  • Eritja, N; Chen, BJ; Rodriguez-Barrueco, R; Santacana, M; Gatius, S; Vidal, A; Marti, MD; Ponce, J; Bergada, L; Yeramian, A; Encinas, M; Ribera, J; Reventos, J; Boyd, J; Villanueva, A; Matias-Guiu, X; Dolcet, X; Llobet-Navas, D

    Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy 13 608-624. .

    [doi:10.1080/15548627.2016.1271512]

  • Eritja, N; Yeramian, A; Chen, BJ; Llobet-Navas, D; Ortega, E; Colas, E; Abal, M; Dolcet, X; Reventos, J; Matias-Guiu, X

    Endometrial Carcinoma: Specific Targeted Pathways

    Advances in Experimental Medicine and Biology 943 149-207. .

    [doi:10.1007/978-3-319-43139-0_6]

  • Jove, M; Gatius, S; Yeramian, A; Portero-Otin, M; Eritja, N; Santacana, M; Colas, E; Ruiz, M; Pamplona, R; Matias-Guiu, X

    Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget 7 52364-52374. .

    [doi:10.18632/oncotarget.10564]

Projectes

  • Implicación de ARID1A en la remodelación del microambiente tumoral y la reprogramación metabólica en el cáncer endometrial
  • Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • Contrato Miguel Servet - RRHH
  • Contrato Miguel Servet - Proyecto
  • LYOTEK
  • "Determinación del perfil metabólico del carcinoma endometrioide de endometrio grado 3 para discriminar los subtipos tumorales establecidos por clasificación del TCGA (The Cancer Genome Atlas Research Network)"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment